Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17104045 | MULTI-STAGE TREATMENT RECOMMENDATIONS | November 2020 | May 2024 | Abandon | 41 | 4 | 0 | Yes | No |
| 17094991 | Document Management System and Method | November 2020 | March 2023 | Abandon | 28 | 1 | 0 | No | No |
| 17007620 | Web-Based Personalized Health Management System | August 2020 | July 2023 | Abandon | 35 | 2 | 0 | No | No |
| 16937577 | Methods of Cross Correlation of Biofield Scans to Enome Database, Genome Database, Blood Test, and Phenotype Data | July 2020 | April 2023 | Abandon | 32 | 1 | 0 | No | No |
| 16891330 | Intelligent Robot-Based Rehabilitation Training Method For Patient With Dementia | June 2020 | February 2023 | Abandon | 32 | 1 | 0 | No | No |
| 16695642 | Systems and Methods for Processing Medical Images For In-Progress Studies | November 2019 | December 2023 | Allow | 48 | 4 | 0 | Yes | No |
| 16689314 | AUTOMATED ELECTRONIC MEDICAL RECORD (EMR) ANALYSIS VIA POINT OF CARE COMPUTING SYSTEMS | November 2019 | August 2024 | Abandon | 57 | 6 | 0 | Yes | No |
| 16689773 | Patient-Centric Eco-System with Automated Workflow and Facility Manager for Improved Delivery of Medical Services | November 2019 | July 2023 | Abandon | 44 | 2 | 0 | No | No |
| 16673726 | PATIENT RISK SCORING AND EVALUATION SYSTEMS AND METHODS | November 2019 | November 2021 | Abandon | 24 | 1 | 0 | No | No |
| 16669357 | METHODS AND SYSTEMS FOR PATIENT CONTROL OF AN ELECTRONIC PRESCRIPTION | October 2019 | August 2023 | Allow | 46 | 3 | 0 | Yes | No |
| 16663223 | STRESS MANAGEMENT IN CLINICAL SETTINGS | October 2019 | August 2022 | Abandon | 34 | 3 | 0 | Yes | No |
| 16659885 | EMOTION DETECTION FROM CONTEXTUAL SIGNALS FOR SURFACING WELLNESS INSIGHTS | October 2019 | March 2022 | Abandon | 29 | 2 | 0 | Yes | No |
| 16583357 | LONGITUDINAL DATA DE-IDENTIFICATION | September 2019 | August 2024 | Abandon | 59 | 6 | 0 | Yes | No |
| 16508653 | METHODS AND SYSTEMS FOR DATA ANALYTICS OF METRICS FOR OUTCOMES AND PAY-FOR-PERFORMANCE MODELS | July 2019 | February 2022 | Abandon | 31 | 2 | 0 | Yes | No |
| 16504565 | IDENTIFICATION OF EPIDEMIOLOGY TRANSMISSION HOT SPOTS IN A MEDICAL FACILITY | July 2019 | September 2023 | Allow | 50 | 4 | 0 | Yes | No |
| 16462291 | SYSTEM AND METHODS FOR CALCULATING, DISPLAYING, MODIFYING, AND USING IMPROVED PERSONALIZED NUTRITIONAL HEALTH SCORE TO ASSESS AND PLAN OPTIMAL DIETS | May 2019 | July 2024 | Abandon | 60 | 6 | 0 | Yes | No |
| 16380248 | RECORDING DEVICE, ORDER ISSUING DEVICE AND ANALYSIS PROCESSING SYSTEM | April 2019 | October 2023 | Abandon | 54 | 6 | 0 | Yes | No |
| 16380019 | ARTIFICIAL INTELLIGENCE AIDED BUG BITE AND TRANSMITTED DISEASE IDENTIFICATION | April 2019 | December 2022 | Abandon | 44 | 4 | 0 | Yes | No |
| 16379640 | CUSTOMIZED HEALTHCARE MANAGEMENT OF A LIVING SUBJECT | April 2019 | May 2021 | Abandon | 25 | 1 | 0 | No | No |
| 16379776 | DATABASE MANAGEMENT SYSTEM FOR DYNAMIC POPULATION STRATIFICATION BASED ON DATA STRUCTURES HAVING FIELDS STRUCTUING DATA RELATED TO CHANGING ENTITY ATTRIBUTES | April 2019 | June 2023 | Abandon | 50 | 4 | 0 | Yes | No |
| 16337742 | DEMENTIA CARE BURDEN LEVEL DETERMINATION DEVICE, METHOD, AND RECORDING MEDIUM, AND DEMENTIA TREATMENT THERAPEUTIC EFFECT DETERMINATION DEVICE, METHOD, AND RECORDING MEDIUM | March 2019 | September 2023 | Abandon | 54 | 5 | 0 | Yes | No |
| 16289654 | SYSTEM AND METHOD FOR ESTIMATING PATHOGEN TRANSFER FROM MOBILE INTERACTION IN CLINICAL ENVIRONMENTS AND A WARNING SYSTEM AND METHOD FOR REDUCING CROSS-CONTAMINATION RISKS | February 2019 | October 2021 | Allow | 32 | 2 | 0 | Yes | No |
| 16288078 | System and Method for the Specialized Delivery of Telemedicine Services | February 2019 | January 2022 | Abandon | 35 | 2 | 0 | No | No |
| 16285757 | MEDICAL RECOMMENDATION PLATFORM | February 2019 | August 2021 | Abandon | 29 | 2 | 0 | No | No |
| 16301451 | COMPUTER SYSTEM FOR RAPID VISUAL TRACKING OF THE STATUS OF ONE OR MORE HOSPITAL DEPARTMENTS | November 2018 | March 2021 | Abandon | 28 | 1 | 0 | No | No |
| 16182278 | COMMUNICATION OF DATA WHERE A SURGICAL NETWORK IS USING CONTEXT OF THE DATA AND REQUIREMENTS OF A RECEIVING SYSTEM / USER TO INFLUENCE INCLUSION OR LINKAGE OF DATA AND METADATA TO ESTABLISH CONTINUITY | November 2018 | July 2023 | Abandon | 56 | 5 | 0 | Yes | No |
| 16178178 | METHOD AND SYSTEM FOR LOCALIZING A HANDHELD ANALYTICAL DEVICE | November 2018 | October 2023 | Abandon | 59 | 5 | 0 | Yes | No |
| 16098021 | ENHANCED DECISION SUPPORT FOR SYSTEMS, METHODS, AND MEDIA FOR LABORATORY BENEFIT SERVICES | October 2018 | March 2021 | Abandon | 29 | 2 | 0 | Yes | No |
| 16141753 | HEALTH EVENT HIGHLIGHTER | September 2018 | June 2023 | Allow | 56 | 6 | 0 | Yes | No |
| 16140414 | PROSPECTIVE MEDICATION FILLINGS MANAGEMENT | September 2018 | October 2023 | Allow | 60 | 6 | 0 | Yes | No |
| 16110233 | System and Method for Populating and Processing Prescription Scripts | August 2018 | January 2021 | Abandon | 29 | 1 | 0 | No | No |
| 16039129 | MINIMALLY INVASIVE PROCEDURE ANALYSIS AND REVIEW SYSTEM AND METHOD | July 2018 | March 2024 | Abandon | 60 | 2 | 1 | Yes | No |
| 16020085 | Patient Support Systems And Methods For Assisting Caregivers With Patient Care | June 2018 | July 2023 | Allow | 60 | 6 | 0 | Yes | No |
| 16066597 | A PATIENT PROCEDURE SCHEDULE THROUGHPUT OPTIMISER SUPERVISED MACHINE LEARNING SYSTEM | June 2018 | December 2020 | Abandon | 29 | 1 | 0 | No | No |
| 16019581 | CLINICAL TRIAL SEARCHING AND MATCHING | June 2018 | May 2021 | Abandon | 34 | 2 | 0 | Yes | No |
| 16066348 | DEVICE, SYSTEM, AND METHOD FOR OPTIMIZING A PATIENT FLOW | June 2018 | February 2021 | Abandon | 32 | 1 | 0 | No | No |
| 16019788 | MANAGEMENT OF COMFORT STATES OF AN ELECTRONIC DEVICE USER | June 2018 | July 2022 | Abandon | 49 | 3 | 0 | Yes | No |
| 16066488 | IMAGE DISPLAY DEVICE AND IMAGE DISPLAY METHOD | June 2018 | June 2021 | Abandon | 36 | 2 | 0 | No | No |
| 16066368 | METHOD AND SYSTEM TO IDENTIFY DOMINANT PATTERNS OF HEALTHCARE UTILIZATION AND COST-BENEFIT ANALYSIS OF INTERVENTIONS | June 2018 | March 2021 | Abandon | 33 | 2 | 0 | No | No |
| 16019865 | AUTOMATED HEALTHCARE SYSTEM | June 2018 | January 2024 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 16019497 | NORMALIZATION OF MEDICAL TERMS | June 2018 | May 2023 | Allow | 59 | 5 | 0 | Yes | No |
| 15773258 | Patient Outcome Tracking Platform | May 2018 | May 2024 | Abandon | 60 | 8 | 0 | Yes | No |
| 15967217 | ROUTE SCHEDULING OF MULTI-CLASS TRANSPORT VEHICLES | April 2018 | December 2021 | Abandon | 43 | 3 | 0 | Yes | No |
| 15966749 | Systems and Methods for Analyzing Health Care Data to Improve Billing and Decision Processes | April 2018 | October 2020 | Abandon | 30 | 1 | 0 | No | No |
| 15772318 | Methods of Cross Correlation of Biofield Scans to Enome Database, Genome Database, Blood Test, and Phenotype Data | April 2018 | October 2020 | Abandon | 30 | 1 | 0 | No | No |
| 15770303 | MIND-ALTERING SUBSTANCE TESTING SYSTEM | April 2018 | May 2024 | Abandon | 60 | 9 | 0 | Yes | No |
| 15955456 | SYSTEM AND METHOD FOR PATIENT TRACKING DURING MASS CASUALTY EVENTS | April 2018 | July 2023 | Allow | 60 | 8 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner RASNIC, HUNTER J.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 0.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner RASNIC, HUNTER J works in Art Unit 3626 and has examined 47 patent applications in our dataset. With an allowance rate of 19.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 43 months.
Examiner RASNIC, HUNTER J's allowance rate of 19.1% places them in the 3% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by RASNIC, HUNTER J receive 3.36 office actions before reaching final disposition. This places the examiner in the 90% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by RASNIC, HUNTER J is 43 months. This places the examiner in the 17% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +30.0% benefit to allowance rate for applications examined by RASNIC, HUNTER J. This interview benefit is in the 77% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 6.2% of applications are subsequently allowed. This success rate is in the 3% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 6.5% of cases where such amendments are filed. This entry rate is in the 8% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
This examiner withdraws rejections or reopens prosecution in 0.0% of appeals filed. This is in the 1% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 100.0% are granted (fully or in part). This grant rate is in the 92% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 33% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 38% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.